Tulsi Therapeutics is actively transferring technology from the United States to enable large-scale manufacturing of affordable, high-quality mesenchymal stem cells and exosomes. Incubated at Aspire Bionest, including the successful testing of its product in an animal model of liver failure. This trial is noteworthy as it marks the first instance globally of combining stem cells an... https://tulsitherapeutics.com/